Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

CytomX Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:CTMX | Benzinga

Q: What sector and industry does CytomX Therapeutics (CTMX) operate in?

CytomX Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Explore CytomX Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CTMX.

Open	$0.63
Close	$0.63
Volume / Avg.	1.21M / 1.80M
Day Range	$0.61 - $0.68
52 Wk Range	0.40 - 5.85
Market Cap	$51.26M
P/E Ratio	1.60
Dividend Yield	-
Exchange	NASDAQ
RSI	55
Short Interest	11.76%
Days to Cover	8.99

Recent News

Why Gap Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Analysts' Varied Perspectives On CytomX's CX-904 Cancer Study: Safety Profile But Caution in Pancreatic Cancer

Initial data from CytomX Therapeutics' CX-904 Phase 1a study shows safety and anti-cancer activity in heavily pretreated patients with advanced metastatic solid tumors. Reductions observed, especially in pancreatic cancer, with stable disease maintained.

Vandana Singh

Gold Moves Higher; Roblox Issues Weak Outlook

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Nov 24

Jan

Mar

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.5

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.63
Close	$0.63
Volume / Avg.	1.21M / 1.80M
Day Range	$0.61 - $0.68
52 Wk Range	0.40 - 5.85
Market Cap	$51.26M
P/E Ratio	1.60
Dividend Yield	-
Exchange	NASDAQ
RSI	55
Short Interest	11.76%
Days to Cover	8.99

About CytomX Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing nove...

Got Questions? Ask

How has CTMX's EPS changed?

What is CTMX's average daily volume?

What is CTMX's free cash flow?

What is the Pivot resistance level for CTMX?

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy CytomX Therapeutics (CTMX) stock?

You can purchase shares of CytomX Therapeutics (NASDAQ:CTMX) through any online brokerage.

View our list of the best stock brokerages

Who are CytomX Therapeutics (CTMX) competitors?

Other companies in CytomX Therapeutics’s space includes: Renovaro (NASDAQ:RENB), Serina Therapeutics (AMEX:SER), Gain Therapeutics (NASDAQ:GANX), bluebird bio (NASDAQ:BLUE) and Immuneering (NASDAQ:IMRX).

What is the forecast, or price target, for CytomX Therapeutics (CTMX) stock?

CytomX Therapeutics has a consensus price target of $5.08.

What is the current price for CytomX Therapeutics (CTMX)?

The stock price for CytomX Therapeutics (NASDAQ: CTMX) is $0.64 last updated April 15, 2025 at 7:45 PM EDT.

Does CytomX Therapeutics (CTMX) pay a dividend?

There are no upcoming dividends for CytomX Therapeutics.

When is CytomX Therapeutics (NASDAQ:CTMX) reporting earnings?

CytomX Therapeutics’s Q1 earnings are confirmed for Wednesday, May 7, 2025.

Is CytomX Therapeutics (CTMX) going to split?

There is no upcoming split for CytomX Therapeutics.

What sector and industry does CytomX Therapeutics (CTMX) operate in?

CytomX Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

CytomX Therapeutics Stock Price, Quotes and Forecasts

CytomX Therapeutics (CTMX) Forecast